Evaluation of the Therapeutic Effect of Syzygium aromaticum Essential Oil in Wistar Rats Infected with Candida albicans - Biochemical and Hematological Study

The objective of this study, on the one hand, is to evaluate the impact of Candida Albicans infection (10 6 CFU per 0.2 ml of intravenous inoculum) on the biochemical and hematological approaches of adult Wistar rats, on the other hand, to test the efficacy of Syzygium aromaticum essential oil (CEO) in restoring or not the harmful effects of the studied yeast with a daily intraperitoneal injection of 0.1 ml CEO/kg. The extraction of the essential oil from S.aromaticum by hydro-distillation allowed us to obtain CEO with a yield of 10.18%. Infection of adult rats with Candida albicans by intravenous injection at a concentration of 106 CFU per 0.2 ml of inoculum increased hepatic and renal fungal load. The infection also revealed a disruption of various biochemical parameters, including liver (AST, ALT), kidney (urea, creatinine) biochemical assays, and hematological (white and red blood cells, platelets...); also, the results show a correction in the values of these parameters following the administration of CEO (by an intraperitoneal injection of 0.1 ml CEO/kg/day) compared to those of infected animals. CEO also corrected the shape of the affected blood cells after infection with C. albicans.